EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Distinct Roles for Thymic Stromal Lymphopoietin ( TSLP ) and IL ‐33 in Experimental Eosinophilic Esophagitis

Anish Dsilva, Ariel Wagner, Michal Itan, Natalie Rhone, Shmulik Avlas, Yaara Gordon, Natalie Davidian, Shraddha Sharma, Elizaveta Razravina, Israel Zan-Bar, Jane R Parnes, Kevin S Gorski und 5 weitere

Allergy · 2025-11 · 80 (11) · 3095-3107

DOI: 10.1111/all.16682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 29.07.2025. Verfasst von Anish Dsilva und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Thymic Stromal Lymphopoietin, Interleukin-33. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Israel Science Foundation, US-Israel Bi-national Science Foundation, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Thymic stromal lymphopoietin (TSLP) and IL‐33 are alarmins implicated in eosinophilic esophagitis (EoE) pathogenesis by activating multiple cells, including mast cells (MCs). Whether TSLP or IL‐33 have a role in EoE and whether their activities are distinct requires further investigation.

Methods

Experimental EoE was induced in wild type (WT) Il33 −/− and Crlf2 −/− mice. TSLP or IL‐5 were neutralized using antibodies. Esophageal histopathology was determined by H&E, anti‐Ki67, anti‐CD31, and anti‐MBP staining. Esophageal RNA was subjected to RNA sequencing. Bone marrow‐derived MCs were activated with TSLP and IL‐13 was determined (ELISA).

Results

TSLP and IL‐33 were overexpressed in human and experimental EoE. Human and mouse esophageal MCs displayed the highest level of Crlf2 (TSLPR) compared to other immune cells. Crlf2 −/− mice were nearly completely protected from EoE, and TSLP neutralization resulted in decreased basal cell proliferation, eosinophilia, lamina propria thickening, and vascularization. Induction of experimental EoE in Il33 −/− mice resulted in reduced eosinophilia, but no alterations in tissue remodeling were observed compared to WT mice. RNA sequencing revealed that TSLP regulates the expression of key genes associated with human EoE (e.g., eotaxins, Il19 , Klk5 , Flg , Il36rn , Il1r2 ) and suggests a role for TSLP in regulating IL‐1 signaling, barrier integrity, and epithelial cell differentiation. Experimental EoE was characterized by a MC‐associated gene signature and elevated MCs. Activation of MCs with TSLP resulted in the secretion of IL‐13.

Conclusion

TSLP and IL‐33 have non‐redundant functions in experimental EoE. This study highlights TSLP as an upstream regulator of IL‐13 and a potential therapeutic target for EoE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eosinophilic EsophagitisThymic Stromal LymphopoietinInterleukin-33MaleAnimalsMiceMice, Inbred C57BLMice, KnockoutDisease Models, AnimalMast CellsEosinophilsSignal TransductionHumansReceptors, Cytokine

Stichwörter der Autor:innen

IL‐33TSLPallergyeosinophilic esophagitis

Substanzen

TSLP protein, mouseThymic Stromal LymphopoietinIl33 protein, mouseInterleukin-33TSLP protein, humanIL33 protein, humanReceptors, Cytokine

Autor:innen und Institutionen

  • Department of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
  • Early Development, Amgen, Thousand Oaks, California, USA.
  • Clinical Biomarkers and Diagnostics, Amgen, South San Francisco, California, USA.
  • Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Research Center for Digestive Tract and Liver Diseases, Sourasky Medical Center, Tel Aviv, Israel.
  • Center for Fundamental Immunology, Benaroya Research Institute, Seattle, Washington, USA.

ORCID-Profile: Ariel Munitz

Förderung

  • Israel Science Foundation
  • US-Israel Bi-national Science Foundation
  • AstraZeneca
  • Israel Cancer Research Fund
  • Israel Cancer Association USA
  • Azrieli Foundation Canada-Israel
  • Campaign Urging Research for Eosinophilic Disease
  • NIDDK NIH HHS

Zitieren

APA

Dsilva, A., Wagner, A., Itan, M., Rhone, N., Avlas, S., Gordon, Y., Davidian, N., Sharma, S., Razravina, E., Zan-Bar, I., Parnes, J. R., Gorski, K. S., Sherrill, J. D., Varol, C., Ziegler, S. F., Rothenberg, M. E., & Munitz, A. (2025). Distinct Roles for Thymic Stromal Lymphopoietin ( TSLP ) and IL ‐33 in Experimental Eosinophilic Esophagitis. Allergy, 80(11), 3095-3107. https://doi.org/10.1111/all.16682

Vancouver

Dsilva A, Wagner A, Itan M, Rhone N, Avlas S, Gordon Y, et al. Distinct Roles for Thymic Stromal Lymphopoietin ( TSLP ) and IL ‐33 in Experimental Eosinophilic Esophagitis. Allergy. 2025;80(11):3095-3107. doi:10.1111/all.16682

BibTeX
@article{Dsilva2025,
  author = {Dsilva, Anish and Wagner, Ariel and Itan, Michal and Rhone, Natalie and Avlas, Shmulik and Gordon, Yaara and Davidian, Natalie and Sharma, Shraddha and Razravina, Elizaveta and Zan-Bar, Israel and Parnes, Jane R and Gorski, Kevin S and Sherrill, Joseph D and Varol, Chen and Ziegler, Steven F and Rothenberg, Marc E and Munitz, Ariel},
  title = {Distinct Roles for Thymic Stromal Lymphopoietin ( TSLP ) and IL ‐33 in Experimental Eosinophilic Esophagitis},
  journal = {Allergy},
  year = {2025},
  volume = {80},
  number = {11},
  pages = {3095--3107},
  doi = {10.1111/all.16682}
}
Kostenlos starten →